Background:Several studies have demonstrated that the expressions of IFITM3 and NCAPG are closely related to the prognosis of various tumors. However, the mechanism of action of these two is not yet clear. In this study, we have explored the mechanism of action of IFITM3 and NCAPG in the promotion of the invasion and metastasis of hepatocellular carcinoma (HCC). Methods: Specimens of liver cancer and adjacent tissues from 55 HCC patients at the Department of Hepatobiliary Surgery, Second Affiliated Hospital of Nanchang University were collected, and the expressions of NCAPG and IFITM3 were determined by qRT-PCR and Western blotting. Through the analysis of multiple databases, the relationship between IFITM3 and NCAPG was established by the CO-IP method. SiRNA and plasmids were used to downregulate and upregulate IFITM3, and the expression of STAT3/CDK1, NCAPG mRNA, and protein was observed. After downregulating and upregulating the expression of IFITM3 and NCAPG, the ability of HCC cells to invade and metastasize was determined using a scratch test and Transwell assays. After using pathway inhibitors and activators, the expression of NCAPG was observed.Results: According to the database, both IFITM3 and NCAPG were highly expressed in liver hepatocellular carcinoma. We also confirmed that IFITM3 and NCAPG were upregulated in HCC tissues and cells. Furthermore, the bioinformatics analysis and CO-IP indicated that there was a protein interaction between IFITM3 and NCAPG, and that IFITM3 could regulate NCAPG by phosphorylating it. We further confirmed our observations by retrospective experiments. The reuse of pathway inhibitors and activators indicated that IFITM3 could regulate NCAPG through STAT3/CDK1 to promote the invasion and metastasis of HCC. Finally, the animal experiments confirmed that the results were also reproducible in vivo. Conclusion: IFITM3 can regulate NCAPG through STAT3/CDK1 to promote the invasion and metastasis of HCC.